EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loss of Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Tumor Microenvironment and Response to BCG Immunotherapy in a Murine Orthotopic Model of Bladder Cancer

Mugdha V Patwardhan iD, Toh Qin Kane iD, Edmund Chiong, Juwita Norasmara Rahmat iD, Ratha Mahendran iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252413296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Mugdha V Patwardhan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Tumor Microenvironment, Immunotherapy, BCG Vaccine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joseph Lim Boon Tiong Cancer Research Initiative, Joseph Lim Boon Tiong Urology Cancer Research Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Loss of the glutathione-S-transferases Theta 2 (Gstt2) expression is associated with an improved response to intravesical Mycobacterium bovis, Bacillus Calmette-Guérin (BCG) immunotherapy for non-muscle-invasive bladder cancer (NMIBC) patients who receive fewer BCG instillations. To delineate the cause, Gstt2 knockout (KO) and wildtype (WT) C57Bl/6J mice were implanted with tumors before treatment with BCG or saline. RNA was analyzed via single-cell RNA sequencing (scRNA-seq) and real-time polymerase chain reaction (RT-PCR). BCG induced PD-L1 expression in WT mice bladders, while pro-inflammatory TNF-α was upregulated in KO bladders. ScRNA-seq analysis showed that Gstt2 WT mice bladders had a higher proportion of matrix remodeling fibroblasts, M2 macrophages, and neuronal cells. In KO mice, distinct tumor cell types, activated fibroblasts, and M1 macrophages were enriched in the bladders. In WT bladders, the genes expressed supported tumorigenesis and immunosuppressive PD-L1 expression. In contrast, Gstt2 KO bladders expressed genes involved in inflammation, immune activation, and tumor suppression. An 11-gene signature (Hmga2, Peak 1, Kras, Slc2a1, Ankfn1, Ahnak, Cmss1, Fmo5, Gphn, Plec, Gstt2), derived from the scRNA-seq analysis predicted response in NMIBC patients (The Cancer Genome Atlas (TCGA) database). In conclusion, our results indicate that patients with WT Gstt2 may benefit from anti-PD-L1 checkpoint inhibition therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsTumor MicroenvironmentImmunotherapyBCG VaccineGlutathione TransferaseMice, KnockoutMice, Inbred C57BLAnimalsMiceDisease Models, AnimalHumansFemaleGene Expression Regulation, NeoplasticCell Line, TumorB7-H1 Antigen

Stichwörter der Autor:innen

BCGPD-L1bladder cancerglutathione S-transferase theta 2immunotherapyinflammationsingle-cell gene expression analysisurinary bladder neoplasms

Substanzen

BCG VaccineGlutathione TransferaseB7-H1 Antigen

Autor:innen und Institutionen

  • Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
  • Genomics and Data Analytics Core, Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.
  • Department of Urology, National University Hospital, National University Health System, Singapore 119074, Singapore.

ORCID-Profile: Mugdha V Patwardhan, Toh Qin Kane, Juwita Norasmara Rahmat, Ratha Mahendran

Förderung

  • Joseph Lim Boon Tiong Cancer Research Initiative
  • Joseph Lim Boon Tiong Urology Cancer Research Initiative

Zitieren

APA

Patwardhan, M. V., Kane, T. Q., Chiong, E., Rahmat, J. N., & Mahendran, R. (2024). Loss of Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Tumor Microenvironment and Response to BCG Immunotherapy in a Murine Orthotopic Model of Bladder Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413296

Vancouver

Patwardhan MV, Kane TQ, Chiong E, Rahmat JN, Mahendran R. Loss of Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Tumor Microenvironment and Response to BCG Immunotherapy in a Murine Orthotopic Model of Bladder Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413296

BibTeX
@article{Patwardhan2024,
  author = {Patwardhan, Mugdha V and Kane, Toh Qin and Chiong, Edmund and Rahmat, Juwita Norasmara and Mahendran, Ratha},
  title = {Loss of Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Tumor Microenvironment and Response to BCG Immunotherapy in a Murine Orthotopic Model of Bladder Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252413296}
}
Kostenlos starten →